GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM

大菲尼克斯社区临床肿瘤学计划

• 批准号: 2088898
• 负责人: DAVID K KING
• 金额: $ 10.1万
• 依托单位: BANNER GOOD SAMARITAN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 1998-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2088898
• 关键词: antineoplastics; cancer prevention; cancer registry /resource; cancer rehabilitation /care; chemoprevention; clinical trials; community health services; cooperative study; human subject; human therapy evaluation; neoplasm /cancer chemotherapy; neoplasm /cancer education; neoplasm /cancer radiation therapy; neoplasm /cancer therapy; oncology; oncology nursing; patient care; primary care physician

The Greater Phoenix Community Clinical Oncology Program (GPCCOP) is a consortium of five hospitals with 38 investigators led by Principal Investigator David K. King, M.D. Dr. King and many of the investigators have been associated with the CCOP since its initial planning stage in 1982. The continuing long-term goals and specific aims of the GPCCOP include: 1) increased clinical research activities; 2) access to additional clinical trials; 3) further development of cancer control research initiatives and patient accrual; 4) maintenance of quality data management; 3) pharmacy resources to coordinate and manage drug distribution; 6) involvement of primary care physicians in state-of-the-art cancer management and education; and 7) continued development of data management systems to support NCI evaluations. GPCCOP's organizational structure requires the involvement of the Co- Principal Investigators and hospital administrators from each of the participating institutions in the planning and policy-making decisions of the CCOP. The physicians, nurses and administrative staff have active roles in guiding the GPCCOP toward attainment of its goals. This experienced team has demonstrated their commitment and ability to accrue patients to both therapeutic and cancer control protocols while maintaining high levels of quality control and timely submissions. GPCCOP's data management systems were recognized by SWOG in 1991 with the Outstanding Achievement Award. Additional investigators, specializing in medical and radiation oncology, have been recruited to the GPCCOP to ensure the availability of total patient care for the 3000 average new cancer patients seen each year. GPCCOP has experienced a 33% increase in the daily radiation therapy treatments at the facilities, and in 1993 a new outpatient center at Thunderbird Samaritan Medical Center will open with a medical oncology treatment facility and a Radiation Therapy Unit.

大凤凰城社区临床肿瘤学计划（GPCCOP）是一个 由五家医院组成的联合体，38名研究者，由校长领导 调查员大卫K. King，医学博士金博士和许多研究人员 自2001年开始规划以来， 1982. GPCCOP的长期目标和具体目标包括： 增加临床研究活动; 2）获得额外的临床 3）进一步开展癌症控制研究活动， 患者累积; 4）质量数据管理维护; 3）药房 协调和管理药物分配的资源; 6）参与 初级保健医生在国家的最先进的癌症管理和 教育;以及7）继续开发数据管理系统， 支持NCI评估。 GPCCOP的组织结构需要联合国的参与， 来自各研究中心的主要研究者和医院管理人员 参与机构的规划和决策 CCOP。医生、护士和行政人员积极参与 在指导GPCCOP实现其目标方面发挥作用。这 经验丰富的团队已经证明了他们的承诺和能力， 患者的治疗和癌症控制协议， 保持高水平的质量控制和及时提交。 GPCCOP的数据管理系统于1991年获得SWOG的认可， 杰出成就奖。 其他研究人员，专门从事医学和放射肿瘤学， 已被招募到GPCCOP，以确保提供 每年平均有3000名新癌症患者接受治疗。 GPCCOP的每日放射治疗增加了33%， 在设施的治疗，并在1993年一个新的门诊中心， Thunderbird Samaritan医疗中心将开设肿瘤内科 治疗设施和放射治疗单位。